CompaniesDisarm Therapeutics

Disarm Therapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

1

As Collaborator

1

Total Enrollment

207

By Phase

NA: 1

By Status

RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
NCT03348956
NCT03997981
Hover over trial bars to see details

Recent Trials

NCT03997981Lead Sponsor
Chemotherapy Induced Peripheral Neuropathy Natural History Study (EPIPHANY)
N/ARecruiting
200 participants
Started: Jul 3, 2019 · Completed: Apr 9, 2024
NCT03348956Collaborator
Biomarkers in Chemotherapy-Induced Peripheral Neurotoxicity
NACompleted
7 participants
Started: Mar 1, 2018 · Completed: Feb 14, 2022
Related Companies
Eli Lilly
acquired